Search results for "dental management"

showing 3 items of 3 documents

Management of children with autism spectrum disorder in the dental setting

2013

Objectives: This article reviews the present literature on the issues encountered while coping with children with autistic spectrum disorder from the dental perspective. The autistic patient profile and external factors affecting the oral health status of this patient population are discussed upon the existing body of evidence. Material and Methods: The MEDLINE database was searched using the terms ‘Autistic Disorder’, ‘Behaviour Control/methods’, ‘Child’, ‘Dental care for disabled’, ‘Education’, ‘Oral Health’, and ‘Pediatric Dentistry’ to locate related articles published up to January 2013. Results: Most of the relevant studies indicate poor oral hygiene whereas they are inconclusive rega…

Coping (psychology)medicine.medical_specialtyMEDLINEChild Behavior610 Medicine & healthOral HealthOdontologíadental managementOral healthSCHOOLSstomatognathic systemchildrenPARENTSHumansMedicineAutism spectrum disorderDENTISTRY610 Medicine & healthChildPsychiatryGeneral DentistryCompetence (human resources)ORAL-HEALTH STATUSDental Care for ChildrenDental Care for Disabledbusiness.industryDental Care for ChildrenReview-ArticleEDUCATIONMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]Dental Care for Disabledmedicine.diseaseCiencias de la saludstomatognathic diseasesOtorhinolaryngologyChild Development Disorders PervasiveTooth DiseasesAutism spectrum disorderPractice Guidelines as TopicUNESCO::CIENCIAS MÉDICASAutismSurgeryCARIES EXPERIENCEbusinessCARE NEEDSMedicina oral patologia oral y cirugia bucal
researchProduct

Strategie preventive e management odontoiatrico nel paziente a rischio di osteonecrosi delle ossa mascellari associata a farmaco

2017

Osteonecrosis of the jaw (ONJ) drug related is an uncommon but serious and debilitating disease, whose epidemiology and pathogenesis are still unclear. However, in the recent years, knowledge regarding ONJ risk factors has lead to substantial progress in ONJ prevention. Anti-resorptive medicines (e.g. bisphosphonates, denosumab) and anti-angiogenic medicines (e.g bevacizumab, sunitinib) are being used in the treatment of various cancers and in the treatment of several non-oncological conditions, mainly for the osteoporosis. Despite the higher frequencies of ONJ cases in cancer patients, ONJ is becoming more frequent in everyday practice in osteometabolic patients. This due to the higher num…

ONJ dental management prevention dental treatment extraction dental implant
researchProduct

Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumab

2020

Denosumab (DNB) is a bone-targeted medication used to preserve structural integrity and minimise the risk of fragility fractures in metastatic cancer and metabolic bone disorders. DNB targets and binds RANK Ligand, inhibiting osteoclast maturation, function, and survival. In contrast with nitrogen-containing bisphosphonates (N-BPs), DNB does not bind to hydroxyapatite and incorporate into bone; thus, bone cellular remodelling recovers rapidly after drug suspension. Denosumab has benn linked to the occurrence of osteonecrosis of the jaw (MRONJ), a uncommon but severe oral side effect with a higher prevalence in metastatic cancer patients than in patients with metabolic bone fragility. Althou…

Oncologymedicine.medical_specialtySide effectbusiness.industrymedicine.medical_treatmentosteonecrosis of the jawsCancerdental managementdenosumabmedicine.diseaseMetabolic Bone DisorderOsteoclast maturationDenosumabdental management denosumab osteonecrosis of the jawsInternal medicineMedicineDosingbusinessOsteonecrosis of the jawReduction (orthopedic surgery)medicine.drug
researchProduct